Previous Page  10 / 25 Next Page
Information
Show Menu
Previous Page 10 / 25 Next Page
Page Background

Notes:

Page 34

Bioplastics 2016

November 10-11, 2016

Volume 7 Issue 6(Suppl)

J Bioremediat Biodegrad

ISSN: 2155-6199 JBRBD, an open access journal

conferenceseries

.com

November 10-11, 2016 Alicante, Spain

International Conference on

Sustainable Bioplastics

Daniel Brannum, J Bioremediat Biodegrad 2016, 7:6(Suppl)

http://dx.doi.org/10.4172/2155-6199.C1.005

Reconstitution of collagen triple helix in physically crosslinked hydrogels and films

Daniel Brannum

Case Western Reserve University, USA

The demand for viable materials to treat medical solutions such as tissue regeneration and bone regrowth in modern day

medicine has not yet been met. Though there have been many breakthroughs, in recent decades the advances are unfortunately

incremental. Collagen, being the most abundant protein found in the human extracellular matrix has been an attractive option

for treatment in these fields. However, properties such as thermal stability, solubility, and reconstitution of hierarchical structure

have proven to be challenging. Due to the poor solubility in standard solvents people have heated solution, used organic acids,

or even electrospun collagen mats. These methods destroy hydrogen bonding, denaturing the collagen into random coil type

polymers. The presented research highlights a benign solvent system that allows for an increase in collagen concentration levels

orders of magnitude higher than previously cited in literature. At the same time the collagen solution only temporarily disrupts

the hydrogen bonding making it possible to reconstitute the natural triple helix. This method is then used to form physical

crosslinked hydrogels and dry films. For additional stability and comparison of mechanical properties, chemical crosslinking

through known natural methods, such as genipin and riboflavin, were used. The fundamental understanding of collagen and

how to mimic physiological conditions will bring forward new advances in medical applications.

Biography

Daniel Brannum is starting his 5

th

year in the Macromolecular Science and Engineering Department at Case Western Reserve University. He has 2 patents pending

and multiple papers in preparation. During his time in graduate school, he has received the Bayer Award for excellence in research, dedication, and contribution to

the scientific community and earned internship positions at 3 different Fortune 500 companies.

djb172@case.edu